Greg Call, PhD, is a Senior Oncology Medical Science Liaison at AstraZeneca, where they are involved in advancing cancer therapies. Previously, they worked as a Clinical Research Scientist in the Investigational Cancer Therapeutics Department at MD Anderson Cancer Center, focusing on coordinating clinical trials and preparing research protocols for publication. Their earlier roles included positions at Tempus Labs and Myriad Genetics, where they specialized in genetic testing for hereditary cancer. Greg earned a PhD in Molecular and Cellular Biology from Baylor College of Medicine and completed their undergraduate studies in Physiology and Developmental Biology at Brigham Young University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices